Neoplasms Malignant Clinical Trial
Official title:
Immune and Skeletal Muscle Response to an Exercise Session in Cancer Survivors
The aims of this study examine the immune system, muscle metabolism, and autonomic nervous system response to an acute bout of exercise. Cancer survivors will participate in an acute bout of exercise. Blood samples will be collected before the exercise bout and at two time points after the exercise bout to assess the proposed variables.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04047290 -
A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT04600206 -
Existential Distress in Patients With Advanced Cancer and Their Caregivers
|
||
| Terminated |
NCT01243762 -
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
|
Phase 1 | |
| Completed |
NCT04728334 -
A Phase 1 Dose Escalation and Expansion Study of AK117
|
Phase 1 | |
| Terminated |
NCT01121588 -
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
|
Phase 1 | |
| Recruiting |
NCT05939687 -
Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection
|
Phase 3 | |
| Recruiting |
NCT06018142 -
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
|
||
| Recruiting |
NCT05758571 -
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT04637295 -
Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19
|
||
| Completed |
NCT04479579 -
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
|
Phase 4 | |
| Recruiting |
NCT04230772 -
Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer
|
N/A | |
| Not yet recruiting |
NCT05650385 -
A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT04616846 -
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
|
N/A | |
| Completed |
NCT04349969 -
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104
|
Phase 1 | |
| Recruiting |
NCT04721756 -
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
|
Early Phase 1 |